key: cord-0820945-br9mb4ch
authors: Mohieldin Mahgoub Ibrahim, Mostafa; Colucci, Maria Eugenia; Veronesi, Licia; Viani, Isabella; Odone, Anna; Arena, Mattia Pia; Incerti, Monia; Tamburini, Elisa; Zoni, Roberta; Pasquarella, Cesira; Affanni, Paola
title: Virological surveillance of SARS-CoV-2 in an Italian Northern area: differences in gender, age and Real Time RT PCR cycle threshold (Ct) values in three epidemic periods
date: 2021-10-01
journal: Acta Biomed
DOI: 10.23750/abm.v92is6.12268
sha: 62652b7d08870079174ce686720e1fa42e48cd8c
doc_id: 820945
cord_uid: br9mb4ch

BACKGROUND AND AIM OF THE WORK: Coronavirus Disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a global public health emergency. The aim of this study was to investigate cases characteristics and Real Time RT PCR cycle threshold (Ct) values distribution of COVID-19 in an Italian Northern area during three periods: first period, February-May 2020; second period, June-August 2020; third period, September 2020-February 2021. METHODS: Real Time RT PCR was used to detect SARS-CoV-2 in respiratory samples (oro/nasopharyngeal swabs). RESULTS: A total of 254,744 samples were tested during the study period. Out of 20,188 positive samples (7.92%), 10,303 were females (51.04%) and 9,885 were males (48.96%). The percentage of positivity varied during the three different periods: 14.1% in the first period, 1.4% in the second and 9.2% in the third. The lowest Ct values were observed in the first phase of pandemic, with an overall average of 25.64. Overall average of the Ct values was lower in males than in females, 26.29 ± 6.04 and 26.84 ± 5.99 respectively. The oldest patients recorded lower Ct values. CONCLUSIONS: The findings of our study represent further evidence in support of the fact that male sex and older age showed lower Ct values, which means higher viral loads and higher infectious potential. These knowledges are useful to better understand the epidemiological aspects of COVID-19 and to perform effective Public Health Policies.

Italy was the first country in Europe to be hit by COVID-19, and most heavily (1) , with the first indigenous case reported in February 2020 (2, 3) . Gender and age are the main factors associated with risks and consequences of the SARS-CoV-2 pandemic (4, 5, 6) . Recent studies indicated that the positivity rate is different in gender, and women had fewer complications than men (7, 8) . Moreover, the severity of the SARS-CoV-2 was found to be both more serious among men than among women, and to be influenced by prior comorbidity (9, 10) . Lastly, the fatality rates were valued to be higher among older age groups, while lower prevalence and milder symptoms were assessed among children respect to adults (4, (12) (13) (14) (15) . The aim of this study was to investigate the positivity rate in relation to gender, age and Real Time RT PCR cycle threshold (Ct) values in the COVID-19 pandemic within three different periods.

This cross-sectional study was conducted from February 2020 to February 2021 at the Laboratory of Hygiene and Public Health of University of Parma, Reference Influenza and SARS-Cov-2 Surveillance Centre for Emilia-Romagna Region. Positive samples were analysed by gender, age and Ct values as a proxy indicator for viral load during three different COVID-19 pandemic periods: first period, February-May 2020 corresponding to the first wave of COVID-19 pandemic; second period, June-August 2020 corresponding to the intermediate period; third period, September 2020-February 2021 corresponding to the second wave of Covid-19 pandemic. Viral RNA was detected in oro/nasopharyngeal swabs obtained both from inpatients and outpatients. COVID-19 infection was confirmed according to the Ct values for N1 and N2 genes ascertained by RT-PCR assay as described by the Centers for Disease Control and Prevention (CDC) (16) . Oro/nasopharyngeal swabs were processed by using several analysis lines; only some of them provided the Ct values and these were mostly used to process oro/nasopharyngeal swabs from hospitalized patients.

Statistical analyses were performed using SPSS 26.0 (IBM, Chicago, ILL). Data were presented as mean, standard deviation (SD), 95% confidence intervals (C.I.) or proportions as appropriate. We used One-way ANOVA to compare the differences of means between groups in a univariate analysis. Twoway ANOVA was used in a multivariable analysis to model the relationship between Ct values (outcome), age and gender group (independent variables). A p value < 0.05 was considered as statistically significant.

A total of 20,188 samples out of 254,744 analysed were positive for SARS-Cov-2 (7.92%) over the study period. The percentage of positivity varied during the three different observed periods: 14.1% in the first period, 1.4% in the second period and 9.2% in the third period. Table 1 shows characteristics of positive samples by gender and age in the different months over the 13 months study period. The first period, from February to May 2020 included the national lockdown period with the peak of positivity rate reached in March (42.98%). A clear decrease in positivity rate Table 1 . SARS-CoV-2 positive sample characteristics by gender and age in the different months. At the beginning of the pandemic (February-March 2020), percentage of positive samples was higher in males than in females, while in the other months, except for July and October, females showed highest percentages. Overall, positive samples were 10,303 (51.04%) in female and 9,885 (48.96%) in male with a ratio of 1.05:1 ( Table 1 ). The mean age of positive subjects, varied over time; in the first period both males and females showed a higher mean age compared with the other two periods, with higher mean age in female than in male subjects. In the second phase, mean age decreased in both genders, and during the third phase mean age increased again but did not return to the levels of the first wave (Table 1) . This observation was consistent for males and females (two tail Pearson's test correlation, p<0.001) even if there was significant difference in positivity rate between males and females in the entire period of pandemic (p<0.001). As expected, based on Italian demographic structure, the majority of the positive subjects over 90 were women (73.08%).

The Ct values were reported for a total of 10,509 samples (52.06%), 5,335 (50.76%) males and 5,174 (49.24%) females. Table 2 shows the Ct values recorded in the different phases, by gender ( Table 2 ). The lowest Ct values were observed in the first phase of pandemic, with an overall average of 25.64. Overall average of Ct values was lower in males than in females, 26.29 ± 6.04 and 26.84 ± 5.99 respectively ( Table 2) . Table 3 shows average Ct values and standard deviation by gender and age group. The relative frequency of samples with Ct progressively increased with increasing age group (Chi-Square test p <0.001); a significant statistical difference was found in the frequency of samples with and without Ct between males and females ( Table 3) .

The lowest average Ct values between 24.26 and 26.13 were observed both in males and females, in > 80 years old group ( Table 3 ). The SARS-CoV-2 Ct values ranged from 10 to 40 and about 31.19% were recorded Ct value ≤ 25 ( Table 4 ).

The relationship between Ct values and age average was inverse and the oldest patients recorded low Ct values which indicates the high concentration of genetic material of SARS-CoV-2 in the samples (Ct 10-14; age mean: male 58.59, female 66.41 and Ct 35-40; age mean: male 53.07; female 55.07) ( Table 4) .

This study investigated the positivity rate of samples in relation to gender, age and Ct values in the COVID-19 pandemic within three different periods from February 2020 to February 2021. Distributions by age, gender and Ct values reflect three different moments of the pandemic over the first pandemic year: first wave, intermediate period, second wave. During the first wave, in February and March 2020, men were more affected than women and both with lower Ct values. As underlined in a previous paper (17) , higher Ct values are justified by the fact that most of the samples came from hospitalized patients with medium-severe clinical symptoms, with a high dispersion of the virus in the environment (18) . After the first wave, oro-nasopharingeal swabs were extended also to non-hospitalized patients highlighting an increase of high percentage of positivity in mild or asymptomatic patients. In the intermediate period, from June to August, a decrease of the percentage of positivity was observed, which can be explained by the constantly increased number of non-hospitalized subjects involved in local screening activities. Moreover, the effect of summer climate conditions should be considered as suggested by some authors (19, 20) . Starting from September, a new increase of percentage of positivity was observed though it remained consistently lower than in the first wave; it could reflect the source of the samples, more frequently from non-hospitalized subjects than in the first wave. Mean age of positive subjects, varied among the months; in particular, the most affected age group was over 80 years old, the most fragile group with high prevalence of comorbidity (9, 10, 11) . However, in the pre-vaccination period, several factors, such as a set of distancing measures, awareness, and identification of geographic areas with different colours contributed, to limit the virus circulation, which was explosive in the first phase, and much slower in the second phase, reaching the peak in a longer period of time. In the future collection and analysis of data from the same geographical area will continue with an evaluation, as for the Influenza (21) (22) (23) (24) (25) , of the effect of vaccination campaign started in December 2020. This study aimed at providing a descriptive picture of the pandemic situation in a Northern geographic area, using the valuable data from a Regional SARS-CoV-2 Virological Surveillance Reference Laboratory. The very high number of the samples analysed over a long period of time represents a strength point of our study. However, a great limitation is the lack of consideration of the origin of swabs and the epidemiological criteria used for swab execution, such as contact of a positive case, screening, presence of symptoms, recovery swab. Moreover, clinical data will be considered in order to confirm that male sex and older age carry a higher risk of experiencing adverse clinical outcomes. All these data will be included in further studies to better understand the dynamics of virus circulation in the population and to perform effective targeted preventive measures.

COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population. Acta bio-medica 2020

COVID 19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum: towards a research roadmap

Modelling the COVID-19 epidemic and implementation of populationwide interventions in Italy

Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

COVID-19 deaths in Lombardy, Italy: data in context

Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age

SARS-CoV-2 viral load assessment in respiratory samples

Risk Factors Associated with Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Age-specific COVID-19 casefatality rate: no evidence of changes over time

Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health

COVID-19: the gendered impacts of the outbreak

Pre-existing traits associated with Covid-19 illness severity

Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes. Centers for Disease Control and Prevention

Virological surveillance of SARS-CoV-2 in an Italian northern area: comparison of Real Time RT PCR cycle threshold (Ct) values in three epidemic periods

Detection of SARS-CoV-2 on hospital surfaces

The Evolution of Covid-19 in Italy after the Spring of 2020: An Unpredicted Summer Respite Followed by a Second Wave

Distribution of the SARS-CoV-2 Pandemic and Its Monthly Forecast Based on Seasonal Climate Patterns

Influenza vaccine effectiveness in children: a retrospective study on eight post-pandemic seasons with trivalent inactivated vaccine

On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region

Vaccine hesitancy in COVID-19 times. An update from Italy before flu season starts

Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype

Vaccines against Coronaviruses: The State of the Art. Vaccines (Basel)

We sincerely thank all Colleagues and Volunteers that supported our Laboratory during the epidemic period.

Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.